E
Enzymit
Enzymit is building a new transformation layer for molecular manufacturing
About Enzymit
Enzymit is creating a new transformation layer for manufacturing by combining computational enzyme design, deep learning, and a proprietary high-throughput discovery platform.
Read full description
We develop novel enzymatic pathways and run them in controllable cell-free production systems. This approach merges the selectivity of biology with the precision of chemistry, enabling cleaner and more efficient production.
Our platform has been validated with pharmaceutical-grade hyaluronic acid (HA), produced at kilogram scale with superior consistency and purity compared to fermentation. We are now advancing toward commercial HA supply while expanding the platform to products like heparin and human milk oligosaccharides (HMOs).
At a glance
- Status
- Operational
- Founded
- 2020
- Headquarters
- Rehovot, Israel
- Employees
- 27
- Open positions
- 1
- Dealroom signal
- 82.4/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biochemical, Enzymes, Nutrition, Synthetic Biology, Spinout, Food Innovation, Sustainable Development Goals, Fermentation
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Enzymit.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2024 | $10M | $40M | Sapir Venture Partners · First Star Venture Capital · Khosla Ventures · Grove Ventures | ↗ |
| GRANTOther financing | Nov 2022 | $500K | — | The Israel Innovation Authority | — |
Growth signals
Latest recorded traffic for Enzymit is 1.2K monthly website visits, up 0% over the last three months. Enzymit's team grew 8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
The Israel Innovation Authority
First Star Venture Capital
Series A3 investors entered at this stage
Sapir Venture Partners
Khosla Ventures
Grove Ventures
Other known investors4 additional known investors
Weizmann Institute of Science- DIDIVEdigital
StartLife
Technology Pioneers | World Economic Forum
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Enzymit on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Enzymit’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







